![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07H 21/02 | |
A61K 31/713 | |||
C12N 15/113 |
(11) | Number of the document | 2341943 |
(13) | Kind of document | T |
(96) | European patent application number | 09814902.4 |
Date of filing the European patent application | 2009-09-17 | |
(97) | Date of publication of the European application | 2011-07-13 |
(45) | Date of publication and mention of the grant of the patent | 2018-11-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2009/005214 |
Date | 2009-09-17 |
(87) | Number | WO 2010/033225 |
Date | 2010-03-25 |
(30) | Number | Date | Country code |
136741 P | 2008-09-22 | US | |
136736 P | 2008-09-22 | US |
(72) |
BROWN, Bob, US
|
(73) |
Dicerna Pharmaceuticals, Inc.,
87 Cambridgepark Drive, Cambridge, MA 02140,
US
|
(54) | COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA POSSESSING MODIFICATIONS |
COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA POSSESSING MODIFICATIONS |